경장영양 제제 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품 유형별, 플로우 유형별, 스테이지별, 적응증별, 최종 사용별, 지역별, 경쟁별(2020-2030F)
Enteral Feeding Formulas Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Flow Type, By Stage, By Indication, By End-Use, By Region & Competition, 2020-2030F
상품코드:1703264
리서치사:TechSci Research
발행일:2025년 04월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 경장영양 제제 시장 규모는 2024년에 67억 5,000만 달러에 달하며, 2030년까지 CAGR은 6.75%로, 예측 기간 중 꾸준한 성장이 예측됩니다.
세계의 헬스케어 산업은 패러다임의 변화를 맞이하고 있으며, 전인적 환자 치료에 대한 관심이 높아지고 있습니다. 환자의 웰빙에 필수적인 요소 중 하나는 영양이며, 질병으로 인해 경구 섭취가 불가능한 개인에게 경장영양제는 매우 중요한 솔루션으로 부상하고 있습니다.
시장 개요
예측 기간
2026-2030
시장 규모 : 2024년
67억 5,000만 달러
시장 규모 : 2030년
100억 1,000만 달러
CAGR : 2025-2030년
6.75%
급성장 부문
스탠다드 포뮬러
최대 시장
북미
세계의 경장영양 제제 시장은 미숙아부터 노인에 이르기까지 회복과 전신 건강을 위해 필요한 영양소를 섭취할 수 있도록 하는 데 있으며, 매우 중요한 역할을 하고 있습니다. 경장영양은 튜브를 통해 소화관에 직접 영양을 공급하는 방식입니다. 이 방법은 삼킴 장애, 소화기 질환, 심각한 질병 등으로 인해 경구로 음식을 섭취할 수 없는 경우에 사용됩니다. 경장영양제 또는 경관영양제라고도 하는 경장영양제는 다량 영양소, 비타민, 미네랄을 균형 있게 배합한 특수한 액체 용액입니다. 영아용 조제분유는 영아부터 성인까지 다양한 환자군의 특정 영양 요구 사항에 맞게 설계되어 있습니다. 표준 조제분유, 질환별 조제분유, 당뇨병이나 신부전과 같은 특정 질환에 특화된 조제분유 등 다양한 유형으로 분류할 수 있습니다. 고령화 사회에서는 다양한 건강 상태에 빠지기 쉽고, 이는 정상적인 식사 능력에 영향을 미칠 수 있습니다. 이에 따라 노인의 영양 요구에 맞는 경장영양 제제에 대한 수요가 증가하고 있습니다.
주요 시장 성장 촉진요인
만성질환의 유병률 상승
주요 시장이 해결해야 할 과제
규제상 장애물
주요 시장 동향
기술의 진보
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 고객의 소리
제5장 경장영양 제제 시장 전망
시장 규모·예측
금액별
시장 점유율·예측
제품별(표준 처방, 질환별 처방)
플로우 유형별(간헐 공급 플로우, 연속 공급 플로우)
스테이지별(성인, 소아)
적응증별(알츠하이머병, 영양실조, 암치료, 당뇨병, 만성 신장병, 희귀질환, 연하장애, 통증 관리, 흡수 불량/소화관 장애/설사, 기타)
용도별(병원, 홈케어)
지역별
기업별(2024)
시장 맵
제6장 북미의 경장영양 제제 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 경장영양 제제 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
독일
영국
이탈리아
프랑스
스페인
제8장 아시아태평양의 경장영양 제제 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 남미의 경장영양 제제 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 경장영양 제제 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
남아프리카공화국
사우디아라비아
아랍에미리트
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
최근 동향
제품 출시
합병과 인수
제13장 세계의 경장영양 제제 시장 : SWOT 분석
제14장 경쟁 구도
Abbott Laboratories Inc
Danone S.A
Fresenius Kabi AG
Nestle S.A.
VICTUS Inc.
Primus Pharmaceuticals, Inc.
Meiji Holdings. Co Ltd.
Mead Johnson & Company, LLC
제15장 전략적 제안
제16장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
Global Enteral Feeding Formulas Market was valued at USD 6.75 Billion in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 6.75% through 2030. The global healthcare industry is undergoing a paradigm shift, with a growing focus on holistic patient care. One essential aspect of patient well-being is nutrition, and for individuals who cannot consume food orally due to medical conditions, enteral feeding formulas have emerged as a crucial solution.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 6.75 Billion
Market Size 2030
USD 10.01 Billion
CAGR 2025-2030
6.75%
Fastest Growing Segment
Standard Formula
Largest Market
North America
The Global Enteral Feeding Formulas Market plays a pivotal role in ensuring that individuals, ranging from premature infants to elderly patients, receive the essential nutrients they need for recovery and overall health. Enteral feeding involves providing nutrients directly into the gastrointestinal tract via a tube. This method is employed when individuals are unable to consume food orally due to conditions such as swallowing disorders, digestive issues, or critical illness. Enteral feeding formulas, also known as enteral nutrition or tube feeding formulas, are specialized liquid solutions containing a balanced mix of macronutrients, vitamins, and minerals. These formulas are designed to match the specific nutritional needs of different patient groups, ranging from infants to adults. They can be categorized into various types, including standard formulas, disease-specific formulas, and specialized formulations for specific medical conditions like diabetes or renal failure. The world's aging population is prone to a range of health conditions that can affect their ability to eat normally. This has led to an increased demand for enteral feeding formulas tailored to the nutritional needs of the elderly.
Key Market Drivers
Rising Prevalence of Chronic Diseases
The global enteral feeding formulas market is witnessing substantial growth, primarily driven by the increasing prevalence of chronic diseases. In 2021, cardiovascular diseases remained the leading cause of mortality among non-communicable diseases (NCDs), accounting for at least 19 million deaths. Cancer followed closely, responsible for 10 million fatalities, while chronic respiratory diseases and diabetes contributed to 4 million and over 2 million deaths, respectively including kidney disease deaths linked to diabetes. Collectively, these four disease categories were responsible for 80% of all premature NCD-related deaths, underscoring their significant impact on global healthcare systems and the urgent need for targeted medical and nutritional interventions. As the global burden of conditions such as cancer, neurological disorders, diabetes, and gastrointestinal diseases continues to rise, the demand for enteral nutrition as a critical component of patient care is expanding. In 2020, cancer was a major global health burden, causing nearly 10 million deaths-equivalent to approximately one in every six fatalities worldwide. Chronic diseases often lead to conditions that impair normal eating and digestion, necessitating the use of enteral feeding formulas to ensure proper nutrient intake. For instance, cancer patients undergoing chemotherapy frequently experience severe appetite loss and gastrointestinal complications, making enteral nutrition essential for maintaining strength and immune function. Similarly, neurological disorders such as Parkinson's disease, multiple sclerosis, and stroke often cause dysphagia (difficulty swallowing), further driving demand for liquid-based nutritional support.
Key Market Challenges
Regulatory Hurdles and
One of the primary challenges confronting the enteral feeding formulas market is the complex regulatory landscape. Different countries have varying regulations and standards governing the production, labeling, and marketing of these products. Manufacturers must navigate a maze of regulations to ensure their products comply with local laws while also meeting global quality standards. This not only increases operational complexity but also poses a barrier for new entrants looking to establish themselves in the market.
Key Market Trends
Technological Advancements
Technological advancements in the field of enteral feeding formulas have touched various aspects of the market, revolutionizing both product development and administration methods. Technological innovations have enabled the development of highly specialized and nutritionally advanced enteral feeding formulas. These formulas are designed to cater to the specific nutritional requirements of patients with varying medical conditions, such as diabetes, renal failure, and gastrointestinal disorders. Through precise formulation and the inclusion of bioactive ingredients, these advanced formulas contribute to better patient recovery and improved overall health. Incorporation of cutting-edge delivery systems has revolutionized how enteral nutrition is administered. The development of pumps with programmable features has allowed for the precise delivery of enteral feeding formulas, ensuring that patients receive the required nutrients at the right rate and consistency. Such devices also minimize the risk of overfeeding or underfeeding, reducing potential complications. The integration of Internet of Things (IoT) technology has led to the creation of smart feeding pumps and monitoring devices. These devices can transmit real-time data about patients' nutritional intake, tube placement, and feeding progress to healthcare professionals.
Key Market Players
Abbott Laboratories Inc
Danone S.A
Fresenius Kabi AG
Nestle S.A.
VICTUS Inc.
Primus Pharmaceuticals, Inc.
Meiji Holdings. Co Ltd.
Mead Johnson & Company, LLC
Report Scope:
In this report, the Global Enteral Feeding Formulas Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Enteral Feeding Formulas Market, By Product:
Standard Formula
Disease-specific Formulas
Enteral Feeding Formulas Market, By Flow Type:
Intermittent Feeding Flow
Continuous Feeding Flow
Enteral Feeding Formulas Market, By Stage:
Adults
Pediatrics
Enteral Feeding Formulas Market, By Indication:
Alzheimer's
Nutrition Deficiency
Cancer Care
Diabetes
Chronic Kidney Diseases
Orphan Diseases
Dysphagia
Pain Management
Malabsorption/GI Disorder/Diarrhea
Others
Enteral Feeding Formulas Market, By End User:
Hospitals
Homecare
Enteral Feeding Formulas Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Enteral Feeding Formulas Market.
Available Customizations:
Global Enteral Feeding Formulas Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Enteral Feeding Formulas Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Standard Formula, Disease-specific Formulas)
5.2.2. By Flow Type (Intermittent Feeding Flow, Continuous Feeding Flow)
5.2.3. By Stage (Adults, Pediatrics)
5.2.4. By Indication (Alzheimer's, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Diseases, Orphan Diseases, Dysphagia, Pain Management, Malabsorption/GI Disorder/Diarrhea, Others)
5.2.5. By End-Use (Hospitals, Homecare)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Market Map
6. North America Enteral Feeding Formulas Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Flow Type
6.2.3. By Stage
6.2.4. By Indication
6.2.5. By End User
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Enteral Feeding Formulas Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Flow Type
6.3.1.2.3. By Stage
6.3.1.2.4. By Indication
6.3.1.2.5. By End User
6.3.2. Canada Enteral Feeding Formulas Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Flow Type
6.3.2.2.3. By Stage
6.3.2.2.4. By Indication
6.3.2.2.5. By End User
6.3.3. Mexico Enteral Feeding Formulas Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Flow Type
6.3.3.2.3. By Stage
6.3.3.2.4. By Indication
6.3.3.2.5. By End User
7. Europe Enteral Feeding Formulas Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Flow Type
7.2.3. By Stage
7.2.4. By Indication
7.2.5. By End User
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Enteral Feeding Formulas Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Flow Type
7.3.1.2.3. By Stage
7.3.1.2.4. By Indication
7.3.1.2.5. By End User
7.3.2. United Kingdom Enteral Feeding Formulas Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Flow Type
7.3.2.2.3. By Stage
7.3.2.2.4. By Indication
7.3.2.2.5. By End User
7.3.3. Italy Enteral Feeding Formulas Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Flow Type
7.3.3.2.3. By Stage
7.3.3.2.4. By Indication
7.3.3.2.5. By End User
7.3.4. France Enteral Feeding Formulas Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Flow Type
7.3.4.2.3. By Stage
7.3.4.2.4. By Indication
7.3.4.2.5. By End User
7.3.5. Spain Enteral Feeding Formulas Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Flow Type
7.3.5.2.3. By Stage
7.3.5.2.4. By Indication
7.3.5.2.5. By End User
8. Asia-Pacific Enteral Feeding Formulas Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Flow Type
8.2.3. By Stage
8.2.4. By Indication
8.2.5. By End User
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Enteral Feeding Formulas Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Flow Type
8.3.1.2.3. By Stage
8.3.1.2.4. By Indication
8.3.1.2.5. By End User
8.3.2. India Enteral Feeding Formulas Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Flow Type
8.3.2.2.3. By Stage
8.3.2.2.4. By Indication
8.3.2.2.5. By End User
8.3.3. Japan Enteral Feeding Formulas Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Flow Type
8.3.3.2.3. By Stage
8.3.3.2.4. By Indication
8.3.3.2.5. By End User
8.3.4. South Korea Enteral Feeding Formulas Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Flow Type
8.3.4.2.3. By Stage
8.3.4.2.4. By Indication
8.3.4.2.5. By End User
8.3.5. Australia Enteral Feeding Formulas Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Flow Type
8.3.5.2.3. By Stage
8.3.5.2.4. By Indication
8.3.5.2.5. By End User
9. South America Enteral Feeding Formulas Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Flow Type
9.2.3. By Stage
9.2.4. By Indication
9.2.5. By End User
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Enteral Feeding Formulas Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Flow Type
9.3.1.2.3. By Stage
9.3.1.2.4. By Indication
9.3.1.2.5. By End User
9.3.2. Argentina Enteral Feeding Formulas Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Flow Type
9.3.2.2.3. By Stage
9.3.2.2.4. By Indication
9.3.2.2.5. By End User
9.3.3. Colombia Enteral Feeding Formulas Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Flow Type
9.3.3.2.3. By Stage
9.3.3.2.4. By Indication
9.3.3.2.5. By End User
10. Middle East and Africa Enteral Feeding Formulas Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Flow Type
10.2.3. By Stage
10.2.4. By Indication
10.2.5. By End User
10.2.6. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Enteral Feeding Formulas Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Flow Type
10.3.1.2.3. By Stage
10.3.1.2.4. By Indication
10.3.1.2.5. By End User
10.3.2. Saudi Arabia Enteral Feeding Formulas Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Flow Type
10.3.2.2.3. By Stage
10.3.2.2.4. By Indication
10.3.2.2.5. By End User
10.3.3. UAE Enteral Feeding Formulas Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Flow Type
10.3.3.2.3. By Stage
10.3.3.2.4. By Indication
10.3.3.2.5. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. Global Enteral Feeding Formulas Market: SWOT Analysis
